Analysis compares care quality and efficiency within physician groups that treat Medicare Advantage patients under at-risk ...

In the second part of this roundtable discussion, a panel of key opinion leaders dive into the key risk factors impacting the pharma manufacturing space, and how the industry should aim to address ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

In the second part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains ...

Xcell Biosciences (Xcellbio), an instrumentation company that focuses on cell and gene therapy (CGT) applications, is teaming up Thermo Fisher Scientific, a supplier of analytical instruments, to ...

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based endpoints to ensure successful access, pricing, and long-term market ...

In the first part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses ...

In the final part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, describes what meaningful ...

2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development. In an interview with Applied Clinical Trials at the 2025 DIA Annual Meeting, Brian Ongioni, chief ...

Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping ...